Variant report
Variant | esv2553986 |
---|---|
Chromosome Location | chr9:71894908-71897473 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534313227 | chr9:71894933-71894934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs57032278 | chr9:71894955-71894956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs140354306 | chr9:71894988-71894989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191958728 | chr9:71895013-71895014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150341807 | chr9:71895018-71895019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144993439 | chr9:71895025-71895026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76738336 | chr9:71895040-71895041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4271031 | chr9:71895047-71895048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558778364 | chr9:71895104-71895105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577211148 | chr9:71895271-71895272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117576926 | chr9:71895318-71895319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369480251 | chr9:71895335-71895336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs56108228 | chr9:71895369-71895370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542084087 | chr9:71895425-71895426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs55763820 | chr9:71895545-71895546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs367611205 | chr9:71895717-71895718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563550172 | chr9:71895911-71895912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs56030094 | chr9:71895950-71895951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183536732 | chr9:71895990-71895991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552297534 | chr9:71896077-71896078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188190369 | chr9:71896585-71896586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148962969 | chr9:71896718-71896719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546299498 | chr9:71896745-71896746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534884661 | chr9:71896776-71896777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191846846 | chr9:71896782-71896783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557243091 | chr9:71896783-71896784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569117255 | chr9:71896788-71896789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539245574 | chr9:71896815-71896816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201062042 | chr9:71896884-71896885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555993548 | chr9:71896886-71896887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143706606 | chr9:71896897-71896898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577247427 | chr9:71896942-71896943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527335644 | chr9:71896966-71896967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78840464 | chr9:71897016-71897017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567252355 | chr9:71897017-71897018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138334480 | chr9:71897029-71897030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs28432228 | chr9:71897043-71897044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs28614156 | chr9:71897046-71897047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111414312 | chr9:71897047-71897048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10867283 | chr9:71897050-71897051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs78132869 | chr9:71897051-71897052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144922949 | chr9:71897055-71897056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574451821 | chr9:71897095-71897096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542120992 | chr9:71897099-71897100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563636772 | chr9:71897131-71897132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374520345 | chr9:71897149-71897150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs531177372 | chr9:71897160-71897161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546057986 | chr9:71897181-71897182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs386734784 | chr9:71897239-71897240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7030339 | chr9:71897240-71897241 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 17899364 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Oral cancer | 21386901 | CNVD |
Epilepsy | 22083797 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:71894200-71895000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr9:71894800-71895000 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr9:71894800-71895000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr9:71894800-71895000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr9:71894800-71895200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr9:71895000-71897400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
7 | chr9:71895000-71898000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr9:71895200-71897400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
9 | chr9:71897400-71897600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr9:71897400-71897800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr9:71897400-71898400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr9:71897400-71899000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr9:71897400-71899000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr9:71897400-71899400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |